|
시장보고서
상품코드
2003683
퀴닌 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 용도별, 형태별, 원료별, 최종사용자별, 유통 채널별, 지역별 - 업계 예측(2026-2033년)Quinine Market Size, Share, and Growth Analysis, By Product Type (Quinine Sulfate, Quinine Hydrochloride), By Application, By Form, By Source, By End User, By Distribution Channel, By Region - Industry Forecast 2026-2033 |
||||||
세계의 퀴닌 시장 규모는 2024년에 21억 달러로 평가되었고, 2025년 22억 2,000만 달러에서 2033년에는 34억 9,000만 달러로 확대되어 예측 기간(2026-2033년)에 CAGR 5.8%를 보일 전망입니다.
세계 퀴닌 시장은 주로 항말라리아제 및 의약품 전구체로서의 치료 수요에 의해 주도되고 있으며, 이는 공급망, 가격 책정 및 투자에 큰 영향을 미치고 있습니다. 이 시장에는 키나무 껍질, 추출된 퀴닌 소금, 틈새 음료 향료가 포함되어 있으며, 전염병이 유행하는 지역에서 치료제공급을 유지하고 음료 제조업체에 매우 중요한 역할을 하고 있습니다. 식민지 시대의 나무껍질 거래에서 산업적 추출로 진화한 이 분야는 제1선택 항말라리아제에 대한 내성이 증가함에 따라 다시금 주목받고 있으며, 의료 시스템이 퀴닌에 의존하게 되었습니다. 또한, 프리미엄 칵테일과 크래프트 토닉에 대한 소비자의 관심이 높아지면서 식품용 퀴닌에 대한 수요가 증가하고 있습니다. 이러한 변화하는 상황은 수직적 통합 생산자에게 기회를 가져다주는 동시에 공급 부족 및 기후 변화의 영향과 관련된 위험을 줄이기 위한 효율적인 공급망의 중요성을 강조하고 있습니다.
세계 퀴닌 시장 성장 요인
말라리아가 유행하는 지역에서 말라리아의 지속적인 확산과 효과적인 공중보건 대책에 대한 관심이 다시금 높아지면서 기존 항말라리아 약물에 대한 수요가 증가하고 있으며, 퀴닌는 필수적인 치료 옵션으로 부상하고 있습니다. 의료진과 각국의 보건 정책은 안정적인 공급망과 표준화된 투약 프로토콜의 중요성을 강조하고 있으며, 지속적인 조달 및 제조에 대한 노력을 장려하고 있습니다. 이러한 안정적인 수요는 제약회사들이 생산 능력을 유지하고 엄격한 품질 관리 조치에 투자하도록 유도하여 시장의 안정성을 높이고 임상 및 병원 환경에서 퀴닌의 지속적인 가용성을 보장합니다. 그 결과, 이러한 지원적인 생태계가 세계 퀴닌 시장의 성장을 뒷받침하고 있습니다.
세계 퀴닌 시장 성장 억제요인
세계 퀴닌 시장은 이 약물과 관련된 알려진 부작용과 내약성 문제로 인해 큰 제약에 직면해 있습니다. 이러한 우려로 인해 의료진은 더 안전하거나 더 잘 견딜 수 있는 대체 치료법을 선호하는 경향이 있습니다. 이러한 부작용에 대한 우려는 처방률 감소와 공공 조달을 담당하는 의료 프로그램에서의 주저로 이어질 수 있습니다. 결과적으로 이러한 신중한 태도는 안전을 우선시하는 부문 수요를 감소시키고, 제조업체와 유통업체가 목표 판매량과 시장 침투율을 달성하도록 압력을 가하고 있습니다. 그 결과, 퀴닌의 광범위한 채택에 대한 소극적인 태도가 그 치료 효과를 충분히 발휘하는 것을 방해하고 있습니다.
세계 퀴닌 시장 동향
세계 퀴닌 시장은 현재 제형 혁신과 특수 용도의 출현에 힘입어 역동적인 변화를 겪고 있습니다. 제조업체들은 틈새 시장을 겨냥한 새로운 제형과 표적치료제 개발에 점점 더 집중하고 있으며, 그 결과 특수한 전달 시스템, 병용요법, 다양한 투여 형태가 생겨나고 있습니다. 임상 연구자 및 약국과의 협업 전략을 통해 제품의 포지셔닝을 재조정하고 시장 내 고부가가치 부문을 창출하고 있습니다. 규제 측면의 인센티브는 미충족된 임상적 니즈에 대응하기 위한 차별화된 제품을 장려하고 있으며, 실제 임상에서 유용성을 입증하고 의료진을 참여시키는 방향으로 마케팅 전략이 변화하고 있습니다. 이를 통해 제품의 수명주기를 연장하고 브랜드가 경쟁력 있는 입지를 확보할 수 있게 되었습니다.
자주 묻는 질문
목차
서론
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 퀴닌 시장 규모 : 제품 유형별
세계의 퀴닌 시장 규모 : 용도별
세계의 퀴닌 시장 규모 : 폼별
세계의 퀴닌 시장 규모 : 소스별
세계의 퀴닌 시장 규모 : 최종사용자별
세계의 퀴닌 시장 규모 : 유통 채널별
세계의 퀴닌 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
LSH 26.05.06Global Quinine Market size was valued at USD 2.1 Billion in 2024 and is poised to grow from USD 2.22 Billion in 2025 to USD 3.49 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).
The global quinine market is primarily driven by its therapeutic demand as an antimalarial and pharmaceutical precursor, significantly impacting supply chains, pricing, and investment. This market encompasses cinchona bark, extracted quinine salts, and niche beverage flavoring, making it crucial for maintaining treatment availability in endemic regions and for beverage manufacturers. The sector's evolution from colonial bark trading to industrial extraction has led to its current resurgence due to increased resistance to first-line antimalarials, prompting health systems to rely on quinine. Moreover, heightened consumer interest in premium cocktails and artisanal tonics is spurring demand for food-grade quinine. This evolving landscape presents opportunities for vertically integrated producers and highlights the importance of efficient supply chains to mitigate risks linked to shortages and climate impacts.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Quinine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Quinine Market Segments Analysis
Global quinine market is segmented by product type, application, form, by source, end user, distribution channel and region. Based on product type, the market is segmented into Quinine Sulfate, Quinine Hydrochloride, Quinine Dihydrochloride and Others. Based on application, the market is segmented into Pharmaceuticals, Food & Beverages and Others. Based on form, the market is segmented into Powder, Liquid and Tablets / Capsules. Based on by source, the market is segmented into Natural and Synthetic / Semi-Synthetic. Based on end user, the market is segmented into Hospitals & Clinics, Pharmaceutical Companies, Food & Beverage Manufacturers, Research Institutes and Others. Based on distribution channel, the market is segmented into Online Sales and Offline Sales. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Quinine Market
The ongoing prevalence of malaria in endemic regions, coupled with a renewed focus on effective public health interventions, has bolstered the demand for established antimalarials, with quinine emerging as a vital treatment option. Healthcare professionals and national health initiatives emphasize the importance of consistent supply chains and standardized dosing protocols, fostering ongoing procurement and manufacturing engagement. This steady demand encourages pharmaceutical companies to sustain their production capabilities and invest in rigorous quality control measures, thereby enhancing market stability and ensuring the continued accessibility of quinine within clinical and hospital environments. Consequently, this supportive ecosystem nurtures the growth of the global quinine market.
Restraints in the Global Quinine Market
The global quinine market faces significant restraints due to the known side effects and tolerability issues associated with the drug. These concerns often lead healthcare professionals to favor alternative treatments that may be perceived as safer or more tolerable. Such apprehensions regarding potential adverse reactions can result in reduced prescribing rates and hesitancy from healthcare programs in charge of public procurement. Consequently, this cautious mindset diminishes demand in segments that prioritize safety, putting pressure on manufacturers and distributors to achieve desired volumes and market penetration. As a result, the reluctance to adopt quinine more broadly hinders its therapeutic effectiveness from being fully realized.
Market Trends of the Global Quinine Market
The global quinine market is currently witnessing a dynamic shift driven by formulation innovation and the emergence of specialty uses. Manufacturers are increasingly focusing on developing novel formulations and targeted therapies that cater to niche markets, leading to the creation of specialized delivery systems, combination therapies, and diverse dosing formats. Collaborative strategies with clinical researchers and pharmacies are enhancing product repositioning, generating higher-value segmentation within the market. Regulatory incentives are favoring differentiated products aimed at addressing unmet clinical needs, prompting a shift in marketing strategies towards demonstrating real-world utility and engaging healthcare professionals, thus extending product lifecycles and positioning brands competitively.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
- Pricing Analysis
Global Quinine Market Size by Product Type & CAGR (2026-2033)
- Market Overview
- Quinine Sulfate
- Quinine Hydrochloride
- Quinine Dihydrochloride
- Others
Global Quinine Market Size by Application & CAGR (2026-2033)
- Market Overview
- Pharmaceuticals
- Antimalarial Drugs
- Treatment of Malaria
- Muscle Cramp Treatments
- Food & Beverages
- Tonic Water
- Bitter Flavoring Agents
- Others
Global Quinine Market Size by Form & CAGR (2026-2033)
- Market Overview
- Powder
- Liquid
- Tablets / Capsules
Global Quinine Market Size by Source & CAGR (2026-2033)
- Market Overview
- Natural
- Synthetic / Semi-Synthetic
Global Quinine Market Size by End User & CAGR (2026-2033)
- Market Overview
- Hospitals & Clinics
- Pharmaceutical Companies
- Food & Beverage Manufacturers
- Research Institutes
- Others
Global Quinine Market Size by Distribution Channel & CAGR (2026-2033)
- Market Overview
- Online Sales
- Offline Sales
Global Quinine Market Size & CAGR (2026-2033)
- North America (Product Type, Application, Form, By Source, End User, Distribution Channel)
- US
- Canada
- Europe (Product Type, Application, Form, By Source, End User, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Application, Form, By Source, End User, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Application, Form, By Source, End User, Distribution Channel)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Application, Form, By Source, End User, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Bristol-Myers Squibb
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Mylan N.V.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Hikma Pharmaceuticals PLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AstraZeneca
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novartis AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck & Co., Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Johnson & Johnson
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Amgen Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Gilead Sciences, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takeda Pharmaceutical Company Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- UCB S.A.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Astellas Pharma Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sumitomo Dainippon Pharma Co., Ltd.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Daiichi Sankyo Company, Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
